Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vfend IV PK and Safety in Moderate Renal Impairment
NCT00150319Phase 2Terminated
- Sponsor
- Pfizer
- Start
- Jun 2005
- Primary completion
- Oct 2005
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of voriconazole in fungal infection, sponsored by Pfizer. Started Jun 2005; status: terminated.
02
Drugs
voriconazole
03
Conditions
fungal infection
Beyond the preview
Go deeper on NCT00150319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00150319.